The Board of Directors of Sobi exercises authorisation for repurchase of shares for the purpose of securing the company’s commitments under the incentive programme
The Annual General Meeting of Swedish Orphan Biovitrum AB (publ) (Sobi®) on 9 May 2023, resolved – for the purpose of ensuring that the company can fulfil its commitments under the long-term incentive programme for managers and executives (the Management Programme) resolved by the Annual General Meeting – on a directed share issue of no more than 1,532,014 redeemable and convertible class C shares. Svenska Handelsbanken AB has today subscribed for all 1,532,014 C-shares. The Annual General Meeting also resolved to authorise the Board of Directors to resolve on the repurchase of all